Business Daily from THE HINDU group of publications
Saturday, Feb 03, 2007
ePaper


News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - Mergers & Acquisitions
Strides' new venture buys Oslo co

Our Bureau

Bangalore, Feb. 2

The newly formed joint venture of Strides Arcolab and Invent Farma has acquired Farma Plus of Norway for an undisclosed sum, Strides said in a release here on Thursday. Oslo-based Farma Plus is an emerging player in hospital products in the Scandinavian market. The acquisition was done through the 50:50 venture Plus Farma ehf. It entered into a 100 per cent share purchase agreement with the Oslo-based Farma Plus.

Farma Plus will drive the growth strategies of both Strides and the Iceland-based Invent Farma in the Scandinavian countries, according to Mr Arun Kumar, Vice-Chairman and Managing Director of Strides Arcolab, and Mr Jose Luis Malagarriga, CEO of Invent Farma.

More Stories on : Mergers & Acquisitions | Pharmaceuticals | Overseas Investments

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
DuPont plans knowledge centre in Hyderabad


Pokarna to raise $ 12m via FCCBs
HPCL finalising Yen loan
Amara Raja to foray into 2-wheeler batteries
Punj Lloyd to ramp up engg headcount in India
Strides' new venture buys Oslo co
Asahi Songwon to invest Rs 52 cr in expansion
IL&FS Investment plans private equity fund of $1 b
Aurobindo drug gets approval
Royal Orchid Hotels in pact with Vascon
Tata Chemicals, Total Produce to form 50:50 joint venture
CCEA nod for NTPC-Railways joint venture
GAIL looking at expanding reach in gas biz; in talks with major producers
ONGC slips 3 positions in PFC Energy list
Excise duty facilities withdrawn for three cos
Choubey takes over at GAIL


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line